Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

This study has been terminated.

( Protocol objective could not be met. A new study with amended eligibility criteria will be developed. )

Study NCT00800150 Information provided by City of Hope Medical Center

First Received: November 27, 2008 Last Updated: July 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2010
Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)